Skip to main content
. 2023 Nov 6;14:1241145. doi: 10.3389/fendo.2023.1241145

Table 4.

Hormone replacement therapy.

Case Total Cases N%
Levothyroxine 62 71 87.3%
Glucocorticoid 55 77.5%
Hydrocortisone 46 64.8%
Prednisone 12 16.9%
rhGH 22 31.0%
Desmopressin 56 78.9%
Puberty Induce Therapy 5
Female 1 25 4.0%
Male 4 46 8.7%

rhGH, recombinant human growth hormone.